Hershey Trust Company’s Voyager Therapeutics VYGR Stock Holding History

Hershey Trust Company’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,580	Closed	-$97K	–	9
2023 Q1	$97K	Buy	+12,580	New	+$100K	﹤0.01%	6
2019 Q2	–	Sell	-27,190	Closed	-$520K	–	22
2019 Q1	$520K	Hold	27,190	–	–	0.01%	10
2018 Q4	$256K	Hold	27,190	–	–	﹤0.01%	13
2018 Q3	$514K	Buy	27,190 +12,646	+87%	+$243K	0.01%	6
2018 Q2	$284K	Buy	+14,544	New	+$287K	﹤0.01%	9
2017 Q3	–	Sell	-14,394	Closed	-$129K	–	17
2017 Q2	$129K	Buy	14,394 +8,921	+163%	+$89.8K	﹤0.01%	13
2017 Q1	$72K	Sell	5,473 -1,800	-25%	-$21.8K	﹤0.01%	11
2016 Q4	$93K	Buy	+7,273	New	+$93.4K	﹤0.01%	16

Other funds holding VYGR

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Hershey Trust Company's VYGR Position: Q2 2023 in Review

Hershey Trust Company sold out of Voyager Therapeutics (VYGR) in Q2 2023, closing a stake of 12,580 shares — an estimated $97K sold.

Hershey Trust Company first reported a position in VYGR in Q4 2016 and held it in 8 quarters. The position peaked at $520K in Q1 2019. 106 funds tracked by Wall St. Rank hold VYGR as of Q2 2023.

Hershey Trust Company reported no remaining Voyager Therapeutics position as of Q2 2023 after selling out during the quarter.
Hershey Trust Company sold 12,580 Voyager Therapeutics shares in Q2 2023, an estimated $97K.
Hershey Trust Company first reported a position in Voyager Therapeutics in Q4 2016 and held it in 8 quarters.
Hershey Trust Company's Voyager Therapeutics position peaked at $520K in Q1 2019.
106 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2023.

Based on Hershey Trust Company's 13F filing for Q2 2023, filed 11 Aug 2023.